2020
DOI: 10.1002/acn3.51173
|View full text |Cite
|
Sign up to set email alerts
|

Centromedian thalamic responsive neurostimulation for Lennox‐Gastaut epilepsy and autism

Abstract: The RNS System is not approved in patients under 18, although a critical need for novel treatment modalities in this vulnerable population persist. We present two pediatric patients with drug-resistant epilepsy secondary to Lennox-Gastaut Syndrome (LGS) and autism spectrum disorder (ASD) treated with the RNS System. Both patients have experienced 75-99% clinical seizure reductions in >1 year of follow-up. We illustrate that children with diffuse onset, multifocal epilepsy, including frontal and thalamic circui… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
58
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 57 publications
(58 citation statements)
references
References 23 publications
0
58
0
Order By: Relevance
“…Leveraging the diffuse connectivity profile of this region, the CM has been successfully targeted by DBS for the treatment of drug-resistant PGE ( 8 , 9 , 15 , 35 , 36 ). RNS stimulation of the CM has been applied in adult patients for the treatment of drug-resistant regional neocortical epilepsy ( 37 ), generalized epilepsy ( 26 ), Lennox-Gastaut Syndrome ( 10 , 38 ), and drug-resistant focal onset-seizures ( 39 ). Seizure frequency of patients with implanted RNS systems often continues to improve over months to years, which implicates the role of neural plasticity induced by programmable closed-loop stimulation ( 16 , 23 ).…”
Section: Discussionmentioning
confidence: 99%
“…Leveraging the diffuse connectivity profile of this region, the CM has been successfully targeted by DBS for the treatment of drug-resistant PGE ( 8 , 9 , 15 , 35 , 36 ). RNS stimulation of the CM has been applied in adult patients for the treatment of drug-resistant regional neocortical epilepsy ( 37 ), generalized epilepsy ( 26 ), Lennox-Gastaut Syndrome ( 10 , 38 ), and drug-resistant focal onset-seizures ( 39 ). Seizure frequency of patients with implanted RNS systems often continues to improve over months to years, which implicates the role of neural plasticity induced by programmable closed-loop stimulation ( 16 , 23 ).…”
Section: Discussionmentioning
confidence: 99%
“…A common strategy for implantation of RNS System leads is to combine cortical strip and thalamic depth leads (“corticothalamic” approach) ( Elder et al, 2019 ; Herlopian et al, 2019 ; Burdette et al, 2020 ; Kokkinos et al, 2020 ; Kwon et al, 2020 ). While this is done to disrupt epileptogenic network activity at both the sites of origin and spread, there is also uncertainty about the ability to detect electrographic seizures in thalamic nuclei with the RNS System ( Burdette et al, 2020 ).…”
Section: Introductionmentioning
confidence: 99%
“…Further, neuromodulation targeting brain structures is becoming an increasingly popular treatment for drug-resistant epilepsy [29] , [30] . This includes electrode placement in the centromedian nucleus which is intimately connected to the basal ganglia [31] , [32] . Therefore, identification of relevant interictal biomarkers in these regions are increasing important.…”
Section: Discussionmentioning
confidence: 99%